Medlab Clinical (AU:MDC) has released an update.
Medlab Clinical Limited reported a significant 98.7% drop in revenue, amounting to just $11,894, and a reduced net loss of $2.13 million for the year ended June 2024. The company did not declare any dividends during this period, reflecting ongoing financial challenges. Despite these setbacks, Medlab remains committed to navigating its financial hurdles.
For further insights into AU:MDC stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
